CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate

CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate

Submitted by admin on December 14, 2020 - 11:09am
Source: 
Biopharma Reporter
News Tags: 
CureVac
vaccines
clinical trials
COVID-19
Headline: 
CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate
snippet: 

CureVac has announced today the enrollment of the first participant in the pivotal Phase 2b/3 study of its messenger ribonucleic acid (mRNA) vaccine candidate, CVnCoV, against COVID-19.

Do Not Allow Advertisers to Use My Personal information